SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-12-000013
Filing Date
2012-02-13
Accepted
2012-02-13 14:16:17
Documents
1
Period of Report
2012-02-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5493
  Complete submission text file 0000886163-12-000013.txt   6878
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11085 NORTH TORREY PINES RD #300 LA JOLLA CA 92037
Business Address
FOEHR MATTHEW W (Reporting) CIK: 0001237556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 12597930